FDA grants emergency authorization to Johnson & Johnson vaccine

The Food and Drug Administration granted emergency use authorization to Johnson & Johnson’s Covid-19 vaccine on Saturday

In December, the FDA authorized Covid-19 vaccines from Pfizer-BioNTech and Moderna. Two more vaccines, from AstraZeneca and Novavax, are completing Phase 3 clinical trials, and are expected to apply for FDA authorization in the spring.

NBC FDA grants emergency authorization to Johnson & Johnson vaccine

Bottom line, NBC is admitting that everyone getting these experimental medical products, is part of a Phase 3 clinical trial, whether they admit this to anyone or not.